Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: Ann Thorac Surg. 2022 Dec 12;117(1):206–212. doi: 10.1016/j.athoracsur.2022.12.013

TABLE 2.

Intraoperative and Postoperative Outcomes of Lung Transplant Recipients by PGD Grade

Variable PGD Grade 0/1
(n = 41)
PGD Grade 2/3
(n = 30)
P Value
Pulmonary artery pressure
 Prereperfusion sPAP 45.9 ± 19.7 51.3 ± 21.9 .28
 Postreperfusion sPAP 31.5 ± 8.8 41.0 ± 9.1 <.001
Intraoperative outcomes
 Operative time, h 7.7 ± 1.2 8.0 ± 1.0 .25
 Intraoperative blood transfusion: pRBC 1.7 ± 2.0 2.1 ± 1.9 .34
 Intraoperative blood transfusion: FFP 0.4 ± 1.0 0.7 ± 1.5 .28
 Intraoperative blood transfusion: platelets 0.3 ± 0.7 0.1 ± 0.3 .10
 Ischemic time, h 5.8 ± 1.9 5.4 ± 0.9 .24
 Venoarterial ECMO use 35 (85.4) 28 (93.3) .50
 Venoarterial ECMO time, h 3.3 ± 1.7 3.2 ± 0.6 .79
Post-operative outcomes
 Acute kidney injury 11 (26.8) 15 (50.0) .09
 Dialysis 1 (2.4) 4 (13.3) .20
 Stroke 1 (2.4) 2 (6.7) .78
 Bowel ischemia 0 (0) 1 (3.3) .87
 Digital ischemia 0 (0) 2 (6.7) .34
 Intensive care unit stay, d 12.2 ± 8.8 25.4 ± 21.8 <.001
 Posttransplant ventilator, d 5.2 ± 7.0 11.3 ± 19.4 .07
 Hospital stay, d 19.8 ± 11.8 29.4 ± 21.4 .02

Values are presented as mean ± SD or n (%). ECMO, extracorporeal membrane oxygenation; FFP, fresh frozen plasma; PGD, primary graft dysfunction; pRBC, packed red blood cells; sPAP, systolic pulmonary artery pressure.